Inhibition of type 1 and type 2 5alpha-reductase activity by free fatty acids, active ingredients of Permixon.
about
Modern extraction techniques and their impact on the pharmacological profile of Serenoa repens extracts for the treatment of lower urinary tract symptomsBenign prostatic hyperplasia: An overview of existing treatment.DNA barcode authentication of saw palmetto herbal dietary supplementsNot all brands are created equal: a comparison of selected components of different brands of Serenoa repens extract.The role of a lipido-sterolic extract of Serenoa repens in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia.Identification of a new plant extract for androgenic alopecia treatment using a non-radioactive human hair dermal papilla cell-based assayPreventing diseases of the prostate in the elderly using hormones and nutriceuticals.Fatty acid and phytosterol content of commercial saw palmetto supplements.Pharmacological effects of saw palmetto extract in the lower urinary tractIn vitro effect of D-004, a lipid extract of the fruit of the cuban royal palm (Roystonea regia), on prostate steroid 5α-reductase activity.Plasma levels, tissue distribution, and excretion of radioactivity after single-dose administration of ((3)H)-oleic acid added to D-004, a lipid extract of the fruit of Roystonea regia, in ratsEffects of D-004, a lipid extract of the fruit of the Cuban royal palm (Roystonea regia) or the lipidosterolic extract of saw palmetto (Serenoa repens) on the sexual activity in male rats: A controlled, experimental study.Hair loss and herbs for treatment.Potential targets in the discovery of new hair growth promoters for androgenic alopecia.New chalcanonol glycoside from the seeds of saw palmetto: antiproliferative and antioxidant effects.Lipidosterolic extract of serenoa repens modulates the expression of inflammation related-genes in benign prostatic hyperplasia epithelial and stromal cells.Androgen-independent effects of Serenoa repens extract (Prostasan®) on prostatic epithelial cell proliferation and inflammation.Antiandrogenic activity of anthranilic acid ester derivatives as novel lead structures to inhibit prostate cancer cell proliferation.Hypothesis on Serenoa repens (Bartram) small extract inhibition of prostatic 5α-reductase through an in silico approach on 5β-reductase x-ray structure.Effect of Saw Palmetto Supplements on Androgen-Sensitive LNCaP Human Prostate Cancer Cell Number and Syrian Hamster Flank Organ Growth.Clinical and instrumental study of the efficacy of a new sebum control cream.Effects of coconut oil on testosterone-induced prostatic hyperplasia in Sprague-Dawley rats
P2860
Q21256691-A4E54E1D-FFFF-4159-ADD0-518E7FB170F1Q34706497-847C3C99-8EE7-4DE4-9FCC-A7EE07ECD55AQ35068626-531D2937-B195-46B3-87E1-37CBB34D5741Q35854081-204E4CAB-AC24-4554-B9CB-CFD49F679886Q35855002-DA691E39-4CA7-44D9-BCDB-4DAC0F2B5169Q35900485-3A28C0D5-BEF8-4194-902A-07A6A740437DQ36021075-E591E466-1F62-4C84-BF6F-67B67EE590F1Q37235402-9C20C23F-5BD0-4968-880C-9339FD234CB3Q37406930-C122021E-2240-4B71-B3B0-9B9CE4314E9AQ37663475-C47C57A1-29D7-4A10-AD5C-03A4782BF1D9Q37663481-955F3DB7-58DE-404B-B6D7-99C1E02EF964Q37672774-C50AB059-5DEE-45F2-9F6C-4213B8C781C8Q38132839-6746C9C7-C255-4E3E-8805-52E6D70DAB2FQ38215774-6F8EC117-BC2F-4F6C-8BEB-047E7576453AQ38955632-783D6D6A-D3F3-4F93-94AE-35C22D0357CCQ39127025-C019C8B0-3A79-4B38-8168-F4BBA3C8F635Q39527993-71F450FD-DADC-43C4-8AB8-CF83103EA0A9Q39570454-E0A08C92-AF8E-406B-B4D1-6BEEA2647450Q42198644-4B8F3477-DC6A-46CC-8830-2CB5D0C7B04AQ42718194-6C91262D-F3AA-4C9E-B4F5-37A61BC13EE3Q50996148-357D55B4-CEDF-4276-9E44-3DC0457E01F5Q56906851-139568F2-FEC0-4ED0-A59B-CEFBC8BC8B27
P2860
Inhibition of type 1 and type 2 5alpha-reductase activity by free fatty acids, active ingredients of Permixon.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Inhibition of type 1 and type ...... ctive ingredients of Permixon.
@ast
Inhibition of type 1 and type ...... ctive ingredients of Permixon.
@en
Inhibition of type 1 and type ...... ctive ingredients of Permixon.
@nl
type
label
Inhibition of type 1 and type ...... ctive ingredients of Permixon.
@ast
Inhibition of type 1 and type ...... ctive ingredients of Permixon.
@en
Inhibition of type 1 and type ...... ctive ingredients of Permixon.
@nl
prefLabel
Inhibition of type 1 and type ...... ctive ingredients of Permixon.
@ast
Inhibition of type 1 and type ...... ctive ingredients of Permixon.
@en
Inhibition of type 1 and type ...... ctive ingredients of Permixon.
@nl
P2093
P1476
Inhibition of type 1 and type ...... ctive ingredients of Permixon.
@en
P2093
Henri Cousse
Jean Pierre Raynaud
Pierre Marie Martin
P304
P356
10.1016/S0960-0760(02)00187-5
P577
2002-10-01T00:00:00Z